Sypsa V - Search Results

1

HIV outbreaks among people who inject drugs in Europe, North America, and Israel.

Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, Chemtob D, Seguin-Devaux C, Duwve JM, Fitzgerald M, Goldberg DJ, Hatzakis A, Jipa RE, Katchman E, Keenan E, Khan I, Konrad S, McAuley A, Skinner S, Wiessing L. Des Jarlais DC, et al. Among authors: sypsa v. Lancet HIV. 2020 Jun;7(6):e434-e442. doi: 10.1016/S2352-3018(20)30082-5. Lancet HIV. 2020. PMID: 32504576 Free PMC article. Review.

2

A survey of bloodborne viruses and associated risk behaviours in Greek prisons.

Malliori M, Sypsa V, Psichogiou M, Touloumi G, Skoutelis A, Tassopoulos N, Hatzakis A, Stefanis C. Malliori M, et al. Among authors: sypsa v. Addiction. 1998 Feb;93(2):243-51. doi: 10.1046/j.1360-0443.1998.9322438.x. Addiction. 1998. PMID: 9624725

3

Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users.

Anastassopoulou CG, Paraskevis D, Sypsa V, Psichogiou M, Katsoulidou A, Tassopoulos N, Skoutelis A, Malliori M, Hatzakis A. Anastassopoulou CG, et al. Among authors: sypsa v. J Med Virol. 1998 Nov;56(3):246-52. J Med Virol. 1998. PMID: 9783693

4

Molecular epidemiology of GB virus C/hepatitis G virus in Athens, Greece.

Anastassopoulou CG, Paraskevis D, Tassopoulos NC, Boletis J, Sypsa VA, Hess G, Hatzakis A. Anastassopoulou CG, et al. Among authors: sypsa va. J Med Virol. 2000 Jul;61(3):319-26. doi: 10.1002/1096-9071(200007)61:3<319::aid-jmv6>3.0.co;2-r. J Med Virol. 2000. PMID: 10861639

5

Comparison of smoothing techniques for CD4 data in a Markov model with states defined by CD4: an example on the estimation of the HIV incubation time distribution.

Sypsa V, Touloumi G, Kenward M, Karafoulidou A, Hatzakis A. Sypsa V, et al. Stat Med. 2001 Dec 30;20(24):3667-76. doi: 10.1002/sim.1080. Stat Med. 2001. PMID: 11782025

6

Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees.

Sypsa V, Hadjipaschali E, Hatzakis A. Sypsa V, et al. Eur J Epidemiol. 2001;17(8):721-8. doi: 10.1023/a:1015671627577. Eur J Epidemiol. 2001. PMID: 12086089

7

Clinical evaluation of an HIV-1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion.

Katsoulidou AS, Moschidis ZM, Gialeraki RE, Paraskevis DN, Sypsa VA, Lazanas MC, Tassopoulos NC, Psichogiou MA, Boletis JN, Karafoulidou AS, Hatzakis AE. Katsoulidou AS, et al. Transfusion. 2004 Jan;44(1):59-66. doi: 10.1111/j.0041-1132.2003.00591.x. Transfusion. 2004. PMID: 14692968

8

Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients.

Sypsa V, Psichogiou M, Katsoulidou A, Skoutelis G, Moutafis S, Hadjiconstantinou V, Kakavas J, Kalapothaki V, Boletis J, Hatzakis A. Sypsa V, et al. Am J Kidney Dis. 2005 Feb;45(2):334-43. doi: 10.1053/j.ajkd.2004.09.021. Am J Kidney Dis. 2005. PMID: 15685512

9

Human herpesvirus 8 infection in hemodialysis patients.

Zavitsanou A, Sypsa V, Petrodaskalaki M, Psichogiou M, Katsoulidou A, Boletis J, Hadjiconstantinou V, Karalis D, Kalapothaki V, Hatzakis A. Zavitsanou A, et al. Among authors: sypsa v. Am J Kidney Dis. 2006 Jan;47(1):167-70. doi: 10.1053/j.ajkd.2005.09.019. Am J Kidney Dis. 2006. PMID: 16377398

10

Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.

Katsoulidou A, Moschidis Z, Sypsa V, Chini M, Papatheodoridis GV, Tassopoulos NC, Mimidis K, Karafoulidou A, Hatzakis A. Katsoulidou A, et al. Among authors: sypsa v. Vox Sang. 2007 Jan;92(1):8-14. doi: 10.1111/j.1423-0410.2006.00857.x. Vox Sang. 2007. PMID: 17181585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page